Artanin exhibits acetylcholinesterase (AChE) inhibitory activity and inhibits AChE-induced and self-induced amyloid-beta (Aβ) aggregation, with IC50 values of 51 μM, 98 μM, and 124 μM, respectively; it is associated with biological activities relevant to Alzheimer's disease.